Landscapes / Companies
OriCell Therapeutics Co., Ltd. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 2
Drugs
2
in active trials
Trials
3 active
3 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1/2 | 30 Nov 2026soonPhase 1/2 trial completes | |||
| Next date | 30 Nov 2026 · Phase 1/2 trial completes | ||||
| Also tested for | Relapsed and/or Refractory Multiple Myeloma, Neoplasms, Plasma Cell and 13 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Dec 2026Phase 1/2 trial completes | |||
| Next date | Dec 2026 · Phase 1/2 trial completes | ||||
| Also tested for | Hepatocellular Carcinoma | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021